6108 New Ray Medicine International Holding Ltd. HKEX · China

New Ray Medicine International Holding (6108) news

New Ray Medicine International Holding Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6108, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest New Ray Medicine International Holding news

We have not published a story on New Ray Medicine International Holding yet. When there is news, it will appear here.

Questions about New Ray Medicine International Holding

What is the ticker symbol of New Ray Medicine International Holding?

New Ray Medicine International Holding Ltd. trades under the ticker 6108 on HKEX.

Where is New Ray Medicine International Holding listed?

New Ray Medicine International Holding Ltd. is listed on HKEX.

Which country or territory is New Ray Medicine International Holding listed under?

Our directory records New Ray Medicine International Holding Ltd. under China.

What does New Ray Medicine International Holding do?

Our directory classifies New Ray Medicine International Holding Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of New Ray Medicine International Holding?

The ISIN recorded for New Ray Medicine International Holding Ltd. is BMG647461372.

Does aibio.space cover New Ray Medicine International Holding?

aibio.space lists New Ray Medicine International Holding Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to New Ray Medicine International Holding?

Companies in our directory listed in the same country and business area as New Ray Medicine International Holding: Jinhe Biotechnology Co., Hygeia Healthcare Holdings Co., China Resources Boya Bio-pharmaceutical Group Co., Hybio Pharmaceutical Co., Lepu Biopharma Co., Zhejiang Hisun Pharmaceutical Co..

Investor discussion: New Ray Medicine International Holding

Members talk about New Ray Medicine International Holding (6108). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at New Ray Medicine International Holding, newest first. Each line links the filing it comes from.

Oct 20, 2026Listings
Share consolidation: CHANGE IN BOARD LOT SIZE. Source
Apr 27, 2026Financings
Share or debt issue: (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED ADOPTION OF NEW BYE-LAWS; AND (4) NOTICE OF ANNUAL GENERAL MEETING. Source
Dec 23, 2025Financings
Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source
Dec 5, 2025Financings
Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. Source
Aug 12, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - COOPERATION AGREEMENT AND ESTABLISHMENT OF THE TARGET COMPANY. Source
Aug 6, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - DISPOSAL OF LISTED SECURITIES. Source
Jun 6, 2025Listings
Share consolidation: PROPOSED CAPITAL REORGANISATION. Source
Apr 24, 2025Financings
Share or debt issue: (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED ADOPTION OF NEW BYE-LAWS; AND (4) NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of New Ray Medicine International Holding's own announcements, newest first. Each opens the full release on the newswire that carried it.

Oct 20, 2026HKEXnews
CHANGE IN BOARD LOT SIZE
Oct 12, 2026HKEXnews
RESIGNATION OF EXECUTIVE DIRECTOR
Sep 4, 2026HKEXnews
2025 ANNUAL REPORT - SUPPLEMENTAL INFORMATION
Aug 27, 2026HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026
Jun 18, 2026HKEXnews
THIRD AMENDED AND RESTATED BYE-LAWS
Jun 18, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 18 JUNE 2026
Apr 27, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING
Apr 27, 2026HKEXnews
(1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED ADOPTION OF NEW BYE-LAWS; AND (4) NOTICE OF ANNUAL GENERAL MEETING
Apr 27, 2026HKEXnews
PROPOSED ADOPTION OF NEW BYE-LAWS
Mar 25, 2026HKEXnews
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Dec 23, 2025HKEXnews
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Dec 5, 2025HKEXnews
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Oct 16, 2025HKEXnews
2024 ANNUAL REPORT - SUPPLEMENTAL INFORMATION
Aug 27, 2025HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Aug 12, 2025HKEXnews
DISCLOSEABLE TRANSACTION - COOPERATION AGREEMENT AND ESTABLISHMENT OF THE TARGET COMPANY
Aug 6, 2025HKEXnews
DISCLOSEABLE TRANSACTION - DISPOSAL OF LISTED SECURITIES
Jul 18, 2025HKEXnews
(1) POLL RESULTS OF THE SPECIAL GENERAL MEETING HELD ON 18 JULY 2025; (2) EFFECTIVE DATE OF THE CAPITAL REORGANISATION; AND (3) ADJUSTMENTS TO THE SHARE OPTIONS
Jun 30, 2025HKEXnews
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
Jun 26, 2025HKEXnews
Notification Letter and Request Form to Non-Registered Shareholders
Jun 26, 2025HKEXnews
Notification Letter and Reply Form to Registered Shareholders

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:6108 on TradingView.

Listing details

Company: New Ray Medicine International Holding Ltd.
Ticker: 6108
Listing: HKEX
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: BMG647461372
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction